ReShape Lifesciences Inc
NASDAQ:RSLS

Watchlist Manager
ReShape Lifesciences Inc Logo
ReShape Lifesciences Inc
NASDAQ:RSLS
Watchlist
Price: 3.92 USD 22.5% Market Closed
Market Cap: 1.2B USD

Operating Margin
ReShape Lifesciences Inc

-87.8%
Current
-232%
Average
3.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-87.8%
=
Operating Profit
-6.3m
/
Revenue
7.2m

Operating Margin Across Competitors

No Stocks Found

ReShape Lifesciences Inc
Glance View

Market Cap
1.2B USD
Industry
Health Care

ReShape Lifesciences, Inc. operates as a medical device company, which focuses on technology to treat obesity and metabolic diseases. The company is headquartered in San Clemente, California and currently employs 47 full-time employees. The company went IPO on 2016-10-06. The firm is focused on offering an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band and associated program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. The ReShape Vest System is an investigational minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery. The ReShapeCare Virtual health coaching program is a virtual telehealth weight management program that supports lifestyle changes for all weight-loss patients, to help them keep the weight off over time. The firm's Obalon Balloon System is intended for adults with a body mass index (BMI) of 30 to 40 kilograms/ square meter.

RSLS Intrinsic Value
8.49 USD
Undervaluation 54%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-87.8%
=
Operating Profit
-6.3m
/
Revenue
7.2m
What is the Operating Margin of ReShape Lifesciences Inc?

Based on ReShape Lifesciences Inc's most recent financial statements, the company has Operating Margin of -87.8%.

Back to Top